Clinical usefulness of a newly developed high-sensitive hepatitis B surface antigen (HBsAg) assay for monitoring hepatitis B reactivation

Kumiko Oone(Nagoya City University Hospital), Yasuhito Tanaka(Kumamoto University), Takako Inoue(Kaneka (United States)), Takaaki Goto(Nagoya City University Hospital), Shigeru Sato(Nagoya City University Hospital), Tomoyuki Ohike(Nagoya City University Hospital), Shigeru Kusumoto
Kanzo
July 1, 2019
10.2957/kanzo.60.237
Cited by 8

Related Papers

Cyclosporin A and Its Analogs Inhibit Hepatitis B Virus Entry Into Cultured Hepatocytes Through Targeting a Membrane Transporter, Sodium Taurocholate Cotransporting Polypeptide (NTCP)
|Hepatology|2013|259
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
|Proceedings of the National Academy of Sciences|2019|241
Gut Dysbiosis Associated With Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|187
Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)
|Journal of Biological Chemistry|2013|166
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
|Clinical Infectious Diseases|2015|149